[ad_1]
Commission Chair Ursula von der Leyen talks about Pfizer’s coronavirus vaccine
The Commission’s agreement with the German company BioNTech and Pfizer was recently confirmed by the President of the Commission. “Tomorrow we will approve a contract of up to 300 million doses of the vaccine developed by the German company BioNTech and Pfizer. This is the most promising vaccine until now ”, underlines the president of the Commission, Ursula von der Leyen.
“A safe and effective vaccine is our best chance to defeat the coronavirus and return to our normal life. The last few months The European Commission works tirelessly to secure the doses of possible vaccines“, Underlines.
“Once this vaccine is available, our plan is to develop it quickly, everywhere in Europe,” he said. This will be the fourth contract with a pharmaceutical company to buy vaccines. And more will come. Because we need to have a wide portfolio of vaccines based on different technologies.
WORLD
Bild for Pfizer vaccine: 150 million Europeans will get vaccinated before summer
Bild for Pfizer vaccine: 150 million Europeans will get vaccinated before summer
“We have already started working with member states to prepare national vaccination campaigns,” he said. It should be noted that it was previously announced that the European Union has completed negotiations with the Pfizer and German BioNTech and will sign a contract “in the next few days” for purchase of 300 million doses of its vaccine against Covid.
The distribution will be subject to the approval of the European regulatory authority, the European Medicines Agency (EMA), which has not yet received the clinical trial data from Pfizer / BioNTech: it will examine them for an opinion to the Commission, which will decide on the marketing authorization of the vaccine. We almost arrive. “In the meantime, let’s be wise and stay safe.”
